Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib is effective and safe for treating severe alopecia areata for up to 5 years.

Baricitinib helps with early hair regrowth in people with alopecia areata.

Vemurafenib causes significant skin side effects, requiring regular dermatologist care and sun protection.

Oral tofacitinib can treat both psoriasis and alopecia universalis by normalizing inflammatory pathways.

Baricitinib effectively promotes long-term hair regrowth in alopecia areata patients.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Abrocitinib significantly improved hair regrowth in adolescents with alopecia areata without serious safety issues.

Patients with alopecia areata using Janus kinase inhibitors are not following lab monitoring guidelines.

New treatments targeting the Hedgehog pathway can help treat advanced skin cancer but may have side effects and their effectiveness in early stages is unknown.

Nail changes from immunotherapy can be managed without stopping cancer treatment.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Baricitinib is effective and safe for treating alopecia areata in Korea.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

Ritlecitinib works well and is safe for treating alopecia areata.

Topical ruxolitinib failed to regrow hair in a 66-year-old with alopecia areata.

Targeting specific metabolic and ionic pathways may improve alopecia areata treatment.

Ritlecitinib 50 mg effectively promotes and sustains hair regrowth in alopecia areata patients.

K10 may not prevent tumors as previously thought and might increase benign tumor risk.

Finasteride helps female-pattern hair loss.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

A new test helps find drugs to treat head and neck cancer by targeting c-Rel.

VYN201 shows promise as a safe and effective treatment for non-segmental vitiligo.

Baricitinib effectively treated hair loss and inflammation in a patient with alopecia areata and lichen planopilaris.

Baricitinib effectively regrows hair in severe alopecia areata cases.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

Cialis and Finasteride could be repurposed to treat aggressive melanoma.

Pantethine may boost the immune system's ability to fight sarcoma.

Baricitinib works better than methotrexate for severe alopecia areata.

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.